As SOCs constitute another important source of Ca2+ mostly involved in pulmonary artery remodeling, and L-type voltage-dependent Ca2+ channels are mainly involved in pulmonary artery vasoconstriction, targeting SOCs may be the next challenge to overcome PAH phenotypes. This evidence concerns the gene CISH and pulmonary arterial hypertension.